Azome Therapeutics Alternatives & Competitors
12 companies similar to Azome Therapeutics — Developing selective NLRP3 inflammasome inhibitors for severe inflammatory disea...
Quell Therapeutics
Transformational Therapies, Transforming Lives
London, United Kingdom
4D Molecular Therapeutics
Powering the Future of Genetic Medicines
Emeryville, United States
Tridek-One
We develop first-in-class CD31 checkpoint agonists for the treatment of auto-immune diseas...
Paris, France
RHEACELL GmbH & Co. KG
Innovative Stem Cell Therapies Experts from Heidelberg, Germany
Heidelberg, Germany
Track all Azome Therapeutics competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Vial
Vial is a next-gen pharma company advancing best-in-class biologics and RNA therapeutics a...
San Francisco, United Sta...
Dianthus Therapeutics, Inc.
Building a leading biotech company focused in severe autoimmune diseases.
United States
Mestag Therapeutics
New therapies for inflammatory disease and cancer by targeting fibroblast immunology
London, United Kingdom
LIPUM AB
We have developed a biological drug SOL-116 for treatment of chronic inflammatory diseases
Umea, Sweden
Editas Medicine
What If You Could Repair Broken Genes?
Cambridge, United States
Endeavor BioMedicines
Boldly pursuing development of transformational medicines that may restore hope for patien...
San Diego, United States
-Ltd.-logo. "CV6 Therapeutics, (NI) Ltd."){kind=logo}
CV6 Therapeutics, (NI) Ltd.
CV6 Therapeutics is dedicated to improving patients lives through the development of novel...
United Kingdom
FogPharma
Until everything is druggable.
Cambridge, United States
About Azome Therapeutics
Developing selective NLRP3 inflammasome inhibitors for severe inflammatory diseases
Development of selective antagonists for inflammatory diseases, Research and drug development for severe pulmonary diseases, Collaboration with scientific and research institutions
Healthcare providers, Patients with severe inflammatory pulmonary diseases, Medical research institutions
Drug Discovery, NLRP3 Inflammasome, Inflammatory Diseases, Selective Antagonists, Inflammasome Inhibitors, RHAMM-Derived Antagonists, Inflammatory Pathways, Therapeutics Development, Early-Stage Company, Biopharmaceuticals, Upstream Priming Signal, Disease Modulation, Inflammation Control
B2B, B2D
Licensing, Performance Based, Project Based
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Azome Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Azome Therapeutics on 28 Jan 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 2 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.